ArticleClinical, cosmetic and investigational dermatology2022
The Combination of Red and Blue Light, Radiofrequency and Intense Pulsed Light for the Treatment of Facial Postacne Erythema.
Article in Clinical, cosmetic and investigational dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 6 citations in OpenAlex.
- A Retrospective Analysis of the Clinical Response and Safety of Radiofrequency Microneedling Treatment in Managing Acne Vulgaris.Aesthetic surgery journal. Open forum · 2026Article
- Methods of Quantitative Assessment of the Response of Dilated Skin Blood Vessels to High-Energy Light Treatments.Journal of clinical medicine · 2024Article
- The Combination of Red and Blue Light, Radiofrequency and Intense Pulsed Light for the Treatment of Facial Postacne Erythema [Letter].Clinical, cosmetic and investigational dermatology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Postacne erythema, also referred to as postinflammatory erythema, is a common sequela in acne patients. At present, there is no specific treatment for postacne erythema, and some treatment drugs can even aggravate facial erythema. Objective: Our research sought to evaluate the efficacy of a combination therapy of LED red and blue light, radiofrequency (RF) and intense pulsed light (IPL) for the treatment of postacne erythema. Methods: Patients were treated with red and blue light for 2 weeks, followed by RF for 4 treatments over 8 weeks. Finally, patients were treated with intense pulsed light for 16 weeks. Therapeutic outcomes were evaluated by erythema index, postacne erythema severity grading and clinical photography. Results: After 3 stages of treatment, the percentage of excellent subjects was 79.2%, the percentage of good subjects was 17.2%, and the total effective rate was 96.4%. The mean erythema index decreased from 496.17±79.11 to 89.32±81.58 (p<0.01) after treatment. The postacne erythema lesions were rated clear in 22.4%, faint erythema in 74.4%, dull red in 2.8% and deep red only in 0.4% of subjects after three-stage treatments. Conclusion: Our results show that the combination of red and blue light therapy, RF therapy and IPL therapy is more effective than other treatments reported for facial postacne erythema.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.